Results for: Sanofi

Top-Selling Vaccine Made Cheap Shows Challenge to Merck: Health

Does France have right plan to revive its economy?

BioMarin will continue Pompe disease drug studies

Ahead of the Bell: Biogen shares keep climbing

Drugmakers, Interpol ramp up fight against fakes

Delhi hospitals overflow with hidden dengue epidemic

Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Analysis - Fate of $23 billion L'Oreal stake points to future of Nestle

J&ampJ hunts for dengue fever drugs in tie-up with academia

Drug companies forge partnerships with top schools

FDA accepts application for new Sanofi MS drug

Europe's drugmakers fight off generics

Euro's slide revives hopes of European corporate profits recovery

Exclusive: Bayer, Novartis, others eye Merck's consumer health unit -...

Eli Lilly copy of $8 billion Sanofi insulin wins EU green light

South Africa sets five years to stem military decline

Promising signs seen in test vaccine for dengue

Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets -...

Sanofi held talks with Abbott, Mylan about mature drugs - document

India invites U.S. to discuss IP, market access issues

Big Pharma stands to profit by cleaning out its medicine chests

Sanofi bets on inhaled insulin with MannKind deal

U.S. clears AstraZeneca over heart drug trial

Alternative treatment for cholesterol shows promise